台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    67.2
  • 漲跌
    ▼0.3
  • 漲幅
    -0.44%
  • 成交量
    77
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-永豐金-敦北 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-敦北 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/03/2800.00169.8069.50-1244-0.41%
2024/03/1500.00258.0058.60-2225-0.89%
2024/03/1200.00261.0559.90-2222-0.90%
2024/03/1100.00261.8061.40-2218-0.92%
2024/03/0800.00159.5061.00-1214-0.47%
2024/02/2300.002.552.3352.20-2.5182-1.35%
2024/02/2100.00248.0047.00-2182-1.09%
2024/02/16151.8000.0052.0011830.55%
2024/02/15154.8000.0055.5011770.56%
2023/11/0900.000.533.5033.90-0.5150-0.33%
2023/10/2600.00331.5031.00-396-3.10%
2023/10/1800.00328.0528.05-371-4.22%
2023/06/16122.0000.0022.1011060.93%
2023/06/130.121.9500.0021.950.11170.09%
2023/06/070.123.2000.0023.300.11400.07%
2023/05/09120.0000.0021.5511050.95%
2023/03/300.119.2000.0019.300.1910.11%
2023/03/290.120.2000.0020.200.1870.11%
2023/03/01016.5000.0016.350140.01%
2022/07/2700.00114.2514.15-1109-0.92%
2022/07/26115.1000.0015.0511020.97%
2021/11/25415.5000.0015.404814.94%
2021/08/0500.00316.0015.95-3344-0.87%
2021/06/17017.0000.0016.3504750.00%
2021/05/2700.00117.3017.40-1505-0.20%
2021/05/2500.00216.6016.55-2531-0.38%
2021/05/1900.00617.0116.95-6547-1.10%
2021/05/18518.6100.0017.9055350.93%
2021/05/17519.4000.0019.6055060.99%
2021/05/1400.00218.0017.90-2459-0.44%
2021/05/13419.10918.6019.55-5434-1.15%
2021/05/12917.7500.0017.8093772.38%
2021/03/1200.00116.7516.70-1268-0.37%
2021/03/1100.00116.9016.80-1270-0.37%
2021/03/0900.00116.9516.90-1271-0.37%
2021/03/02318.7300.0017.4032561.17%
2020/11/1000.00119.3020.20-1420-0.24%
2020/10/2600.00121.2020.40-1528-0.19%
2020/10/2000.00119.8019.80-1546-0.18%
2020/10/1500.00114.9014.95-1633-0.16%
2020/10/0800.00116.4516.40-1830-0.12%
2020/10/05117.4000.0017.3511,2120.08%
2020/08/20119.7000.0019.7012,1210.05%
2020/08/19121.7000.0021.8012,1280.05%
2020/07/2900.00124.2025.55-12,273-0.04%
2020/07/2300.00429.6628.80-42,233-0.18%
2020/07/22429.45129.7530.0032,2040.14%
2020/07/21226.8500.0027.4522,1490.09%
2020/07/1600.00129.0529.05-12,018-0.05%
2020/07/15131.50431.0930.80-31,983-0.15%
2020/07/14231.45231.2529.6001,9070.00%
2020/07/13530.96130.7031.5541,7930.22%
2020/07/1000.00627.9028.70-61,666-0.36%
2020/07/09126.1000.0026.1011,5300.07%
2020/07/08123.7500.0023.7511,5160.07%
2020/07/07121.2000.0021.6011,5050.07%
2020/07/06223.7000.0023.1521,4760.14%
2020/07/0300.00124.2024.20-11,434-0.07%
2020/06/1900.00222.6022.20-21,393-0.14%
2020/06/1800.00124.5022.85-11,372-0.07%
2020/06/17125.45125.1025.3501,3500.00%
2020/06/16425.50225.0025.9021,2940.15%
2020/06/15323.4200.0024.2031,2070.25%
2020/06/12121.20121.3522.0001,1240.00%
2020/06/11120.75620.6521.00-51,077-0.46%
2020/06/10218.28118.4019.1019850.10%
2020/06/09117.3000.0017.4019580.10%
2020/06/0300.00317.1017.60-3963-0.31%
2020/06/0200.00116.7016.60-1966-0.10%
2020/05/29218.5500.0018.5029730.21%
2020/05/2800.00517.8018.50-5978-0.51%
2020/05/27421.60121.6019.4539470.32%
2020/05/26121.60121.6021.6009020.00%
2020/05/251219.2100.0019.65129351.28%
2020/05/0600.00112.8512.65-1761-0.13%
2020/05/05112.3000.0012.4017420.13%
2019/12/0900.0039.629.69-385-3.51%
2019/11/22310.2000.009.853943.17%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音